In vivo Proton Magnetic Resonance Spectroscopy of Brain Tumors

The ability of magnetic resonance spectroscopy (MRS) to differentiate neoplastic brain cells and their metabolic and structural characteristics is evaluated. We examined 120 patients with brain tumors using a 1.5-tesla MRI unit and MRS. The peak areas of N-acetyl-aspartate (NAA), phosphocreatine-creatine (Pcr-Cr), choline-containing compounds (Cho), lactate, lipids, myoinositol, amino acids and the ratios of NAA/Pcr-Cr, NAA/Cho and Cho/Pcr-Cr were calculated by a standard integral algorithm. In normal brain tissue, the following metabolites were identified: NAA at 2.0 ppm, Pcr-Cr at 3.0 ppm and Cho at 3.2 ppm. The different concentrations of the metabolites examined and their role in the biochemical profile of different types of tumors are discussed. The confidence interval of the MRS versus pathology was between 0.9 and 0.954, while it was between 0.52 and 0.631 for MRI versus pathology. The Cho/Pcr-Cr ratio is a very important malignancy marker for histologic tumor grading of astrocytomas. The greater this ratio, the higher the grade of the astrocytoma. NAA/Pcr-Cr together with Cho/Pcr-Cr help specify the presence or absence of a neoplasm. Proton MRS is a useful and promising diagnostic modality not only in diagnosing but also in grading solid brain tumors.

[1]  G. Sutherland,et al.  Mobile lipids and metabolic heterogeneity of brain tumours as detectable by Ex Vivo 1H MR spectroscopy , 1994, NMR in biomedicine.

[2]  M Ala-Korpela,et al.  Automated classification of human brain tumours by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes. , 1996, Neuroreport.

[3]  Yasushi Ishii,et al.  Alterations of lactate (+lipid) concentration in brain tumors with in vivo hydrogen magnetic resonance spectroscopy during radiotherapy. , 1997, Investigative radiology.

[4]  R. Zimmerman,et al.  Proton MR spectroscopy of pediatric cerebellar tumors. , 1995, AJNR. American journal of neuroradiology.

[5]  R. Gonzalez,et al.  Imaging of cerebral metastases. , 1996, Neurosurgery clinics of North America.

[6]  Sylvie Grand,et al.  1H mrs of human brain abscesses in vivo and in vitro , 1995, Magnetic resonance in medicine.

[7]  D. Hoffmann,et al.  In vivo sup 1 H MRS of brain abscesses versus necrotic brain tumors , 1996, Neurology.

[8]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[9]  S. Kannuki,et al.  Non‐invasive Characterization of Brain Tumor by in‐vivo Proton Magnetic Resonance Spectroscopy , 1995, Japanese journal of cancer research : Gann.

[10]  K. Houkin,et al.  Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy. , 1997, Neurologia medico-chirurgica.

[11]  K. Laxer.  Clinical Applications of Magnetic Resonance Spectroscopy , 1997, Epilepsia.

[12]  F Lazeyras,et al.  Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. , 1996, AJR. American journal of roentgenology.

[13]  David G. Gadian,et al.  Proton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies , 1990, Journal of computer assisted tomography.

[14]  T R Brown,et al.  Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. , 1996, Journal of neurosurgery.

[15]  F. Lazeyras,et al.  Metabolic imaging in the diagnosis of brain tumors , 1996, Current opinion in neurology.

[16]  R. Zimmerman,et al.  Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. , 1996, AJR. American journal of roentgenology.

[17]  W. Reddick,et al.  Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. , 1996, International journal of radiation oncology, biology, physics.

[18]  H. Poptani,et al.  Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. , 1995, AJNR. American journal of neuroradiology.

[19]  R. Kauppinen,et al.  Quantitative Metabolite Patterns of Human Brain Tumors: Detection by 1H NMR Spectroscopy In Vivo and In Vitro , 1994, Journal of computer assisted tomography.

[20]  J Fan,et al.  Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part II: Clinical analysis. , 1996, Journal of the National Medical Association.

[21]  Bruno Alfano,et al.  1H MR Spectroscopy in Patients with Metastatic Brain Tumors: A Multicenter Study , 1995, Magnetic resonance in medicine.

[22]  S. Byrd,et al.  Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, Part I: Introduction to MRS. , 1996, Journal of the National Medical Association.

[23]  E. Gotsis,et al.  In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors. , 1996, Anticancer research.

[24]  M. Han,et al.  Brain abscess and brain tumor: discrimination with in vivo H-1 MR spectroscopy. , 1997, Radiology.

[25]  J. Frahm,et al.  Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences. , 1991, Journal of computer assisted tomography.

[26]  J. Saunders,et al.  Classification of Brain Tumors by Ex Vivo 1H NMR Spectroscopy , 1995, Journal of neurochemistry.

[27]  B L Miller,et al.  Analysis of brain tumors using 1H magnetic resonance spectroscopy. , 1995, Surgical neurology.

[28]  F. Podo,et al.  Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors. , 1996, Anticancer research.

[29]  In vivo 1H MRS and in vitro multinuclear MR study of human brain tumors. , 1996, Anticancer research.

[30]  Matthijs Oudkerk,et al.  1H MR Spectroscopy Detection of Lipids and Lactate in Metastatic Brain Tumors , 1996, NMR in biomedicine.

[31]  C Van Ongeval,et al.  Localized 1H NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. , 1991, Journal of computer assisted tomography.

[32]  M. Oudkerk,et al.  1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd‐contrast , 1997, Magnetic resonance in medicine.

[33]  H. Poptani,et al.  Cystic intracranial mass lesions: possible role of in vivo MR spectroscopy in its differential diagnosis. , 1995, Magnetic resonance imaging.